Kenji, Shoji F.
Kurma, Keerthi
Collet, Brigitte
Oblet, Christelle
Debure, Laure
Di Primo, Carmelo
Minder, Laëtitia
Vérité, Franck
Danger, Yannic
Jean, Mickael
Penna, Aubin http://orcid.org/0000-0002-1070-5990
Levoin, Nicolas http://orcid.org/0000-0002-7731-736X
Legembre, Patrick http://orcid.org/0000-0001-6649-8049
Funding for this research was provided by:
Etablissement Français du Sang
Ligue Contre le Cancer
Fondation de France
Article History
Received: 25 July 2022
Revised: 12 October 2022
Accepted: 14 October 2022
First Online: 23 October 2022
Competing interests
: PL and MJ are involved in patents protecting the use of CD95 or CD95L in chronic inflammatory disorders and cancers (WO2014118317; WO2015189236; WO2015158810; WO2015104284; WO2017149012; WO2018130679).